Improved ex-vivo expansion of immune cells for use in cell therapy

<b>Abstract</b>
Researchers from Goethe University Frankfurt am Main developed a new method to increase proliferation and viability of immune cells, e.g. natural killer (NK) cells, derived from patients or donors. The obtained NK cell preparations are currently tested preclinically for treatment of leukemia.

Further information: PDF

INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0

Contact
Dr. Otmar Schöller

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Silicone sponge captures unknown bacteria

KIT researchers develop a chip that captures microbial dark matter in air, water, and soil – new tool for biotechnology and medicine. From human intestines to the bottom of the…

An exoplanet atmosphere as never seen before

The JWST just scored another first: a detailed molecular and chemical portrait of a distant world’s skies. The telescope’s array of highly sensitive instruments was trained on the atmosphere of…

AI tailors artificial DNA for future drug development

With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells’ protein production.  The technology can contribute to…

Partners & Sponsors